Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4099972
Max Phase: Preclinical
Molecular Formula: C19H24INO2
Molecular Weight: 298.41
Molecule Type: Small molecule
Associated Items:
ID: ALA4099972
Max Phase: Preclinical
Molecular Formula: C19H24INO2
Molecular Weight: 298.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc2c(cc1OCc1ccccc1)C[N+](C)(C)CC2.[I-]
Standard InChI: InChI=1S/C19H24NO2.HI/c1-20(2)10-9-16-11-18(21-3)19(12-17(16)13-20)22-14-15-7-5-4-6-8-15;/h4-8,11-12H,9-10,13-14H2,1-3H3;1H/q+1;/p-1
Standard InChI Key: SPLZMJVWHJTXHL-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 298.41 | Molecular Weight (Monoisotopic): 298.1802 | AlogP: 3.41 | #Rotatable Bonds: 4 |
Polar Surface Area: 18.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -0.80 | CX LogD: -0.80 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: 0.27 |
1. Crestey F, Jensen AA, Soerensen C, Magnus CB, Andreasen JT, Peters GHJ, Kristensen JL.. (2018) Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts., 61 (4): [PMID:29384668] [10.1021/acs.jmedchem.7b01895] |
Source(1):